The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Avelumab in metastatic castration-resistant prostate cancer (mCRPC).
 
Farhad Fakhrejahani
No Relationships to Disclose
 
Ravi Amrit Madan
Speakers' Bureau - Boehringer Ingelheim (I); Janssen (I); Pfizer (I)
 
William L. Dahut
No Relationships to Disclose
 
Marijo Bilusic
Consulting or Advisory Role - Astellas Pharma; Bayer; Dendreon
Speakers' Bureau - Dendreon
Research Funding - Ambry Genetics (Inst); Bavarian Nordic (Inst); Johnson & Johnson (Inst); Sotio (Inst)
 
Fatima Karzai
No Relationships to Disclose
 
Lisa M Cordes
No Relationships to Disclose
 
Julius Strauss
No Relationships to Disclose
 
Jeffrey Schlom
Research Funding - EMD Serono (Inst)
 
James L. Gulley
Consulting or Advisory Role - Prime Oncology; TRM Oncology
Research Funding - Astellas Medivation (Inst); Bavarian Nordic (Inst); Celgene (Inst); EMD Serono (Inst)
Travel, Accommodations, Expenses - Prime Oncology; TRM Oncology